What is the analyst consensus rating for VRTX?

The analyst consensus rating for VRTX is "Strong Buy" based on 17 analyst recommendations.

What is the average price target for VRTX?

The average 12-month price target for VRTX is $558.50, representing an upside of 27.3% from the current price of $438.71.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Vertex Pharmaceuticals Incorporated (VRTX) Forecast: Analyst Ratings & Targets

Latest VRTX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Mar 18, 2026	Naz Rahman	Maxim	Upgrades	Strong Buy	$575.00
Mar 11, 2026	Joon Lee	Truist	Maintains	Strong Buy	$490.00 → $525.00 +35.00 (7.1%)
Mar 10, 2026	Andrew S. Fein	HC Wainwright	Maintains	Strong Buy	$591.00 → $641.00 +50.00 (8.5%)
Mar 10, 2026	Akash Tewari	Jefferies	Initiates	Strong Buy	$580.00
Mar 10, 2026	Ying Huang	BofA Securities	Maintains	Strong Buy	$571.00 → $598.00 +27.00 (4.7%)
Mar 10, 2026	Geoff Meacham	Citi	Maintains	Strong Buy	$575.00 → $585.00 +10.00 (1.7%)
Mar 10, 2026	Jay Olson	Oppenheimer	Maintains	Buy	$540.00 → $600.00 +60.00 (11.1%)
Mar 10, 2026	Terence Flynn	Morgan Stanley	Maintains	Buy	$570.00 → $596.00 +26.00 (4.6%)
Feb 17, 2026	Whitney Ijem	Canaccord Genuity	Maintains	Hold	$411.00 → $441.00 +30.00 (7.3%)
Feb 17, 2026	Andrew S. Fein	HC Wainwright	Maintains	Strong Buy	$518.00 → $591.00 +73.00 (14.1%)
Feb 17, 2026	Eliana Merle	Barclays	Maintains	Buy	$606.00 → $607.00 +1.00 (0.2%)
Feb 13, 2026	Greg Harrison	Scotiabank	Maintains	Hold	$495.00 → $558.00 +63.00 (12.7%)
Feb 13, 2026	Andrew S. Fein	HC Wainwright	Maintains	Strong Buy	$478.00 → $518.00 +40.00 (8.4%)
Feb 13, 2026	Paul Matteis	Stifel	Maintains	Hold	$445.00 → $466.00 +21.00 (4.7%)
Feb 13, 2026	Jay Olson	Oppenheimer	Upgrades	Buy	$540.00
Feb 13, 2026	Brian Abrahams	RBC Capital	Maintains	Buy	$546.00 → $541.00 -5.00 (-0.9%)
Jan 28, 2026	Eliana Merle	Barclays	Upgrades	Buy	$414.00 → $606.00 +192.00 (46.4%)
Jan 26, 2026	Michael Yee	UBS	Maintains	Strong Buy	$535.00 → $545.00 +10.00 (1.9%)
Jan 23, 2026	Liisa Bayko	Evercore ISI Group	Maintains	Buy	$475.00 → $530.00 +55.00 (11.6%)
Jan 22, 2026	Brian Abrahams	RBC Capital	Upgrades	Buy	$455.00 → $546.00 +91.00 (20.0%)
Jan 12, 2026	William Pickering	Bernstein	Upgrades	Buy	-
Jan 7, 2026	Michael Yee	UBS	Initiates	Strong Buy	$546.00 → $535.00 -11.00 (-2.0%)
Jan 6, 2026	Andy Chen	Wolfe Research	Upgrades	Buy	$548.00

Naz Rahman

Maxim

Strong BuyUpgrades

$575.00

Mar 18

Joon Lee

Truist

Strong BuyMaintains

$490.00 → $525.00

Mar 11

Andrew S. Fein

HC Wainwright

Strong BuyMaintains

$591.00 → $641.00

Mar 10

Akash Tewari

Jefferies

Strong BuyInitiates

$580.00

Mar 10

Ying Huang

BofA Securities

Strong BuyMaintains

$571.00 → $598.00

Mar 10

Geoff Meacham

Citi

Strong BuyMaintains

$575.00 → $585.00

Mar 10

Jay Olson

Oppenheimer

BuyMaintains

$540.00 → $600.00

Mar 10

Terence Flynn

Morgan Stanley

BuyMaintains

$570.00 → $596.00

Mar 10

Whitney Ijem

Canaccord Genuity

HoldMaintains

$411.00 → $441.00

Feb 17

Andrew S. Fein

HC Wainwright

Strong BuyMaintains

$518.00 → $591.00

Feb 17

Eliana Merle

Barclays

BuyMaintains

$606.00 → $607.00

Feb 17

Greg Harrison

Scotiabank

HoldMaintains

$495.00 → $558.00

Feb 13

Andrew S. Fein

HC Wainwright

Strong BuyMaintains

$478.00 → $518.00

Feb 13

Paul Matteis

Stifel

HoldMaintains

$445.00 → $466.00

Feb 13

Jay Olson

Oppenheimer

BuyUpgrades

$540.00

Feb 13

Brian Abrahams

RBC Capital

BuyMaintains

$546.00 → $541.00

Feb 13

Eliana Merle

Barclays

BuyUpgrades

$414.00 → $606.00

Jan 28

Michael Yee

UBS

Strong BuyMaintains

$535.00 → $545.00

Jan 26

Liisa Bayko

Evercore ISI Group

BuyMaintains

$475.00 → $530.00

Jan 23

Brian Abrahams

RBC Capital

BuyUpgrades

$455.00 → $546.00

Jan 22

William Pickering

Bernstein

BuyUpgrades

Jan 12

Michael Yee

UBS

Strong BuyInitiates

$546.00 → $535.00

Jan 7

Andy Chen

Wolfe Research

BuyUpgrades

$548.00

Jan 6

Vertex Pharmaceuticals Incorporated (VRTX) Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest VRTX Analyst Ratings & Recommendations

Frequently Asked Questions